MATINAS BIOPHARMA HOLDINGS, INC. Finance Lease, Liability, to be Paid, Year Four
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Finance Lease, Liability, to be Paid, Year Four of $7.00 thousand as of 2023-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Notes › Commitment and Contingencies › Finance Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour · last filed 2025-04-15
- 2023-12-31: Finance Lease, Liability, to be Paid, Year Four $7.00K.
- 2023-09-30: Finance Lease, Liability, to be Paid, Year Four $7.00K.
- 2023-06-30: Finance Lease, Liability, to be Paid, Year Four $7.00K.
- 2023-03-31: Finance Lease, Liability, to be Paid, Year Four $7.00K.
| Period end | Finance Lease, Liability, to be Paid, Year Four | Finance Lease, Liability, to be Paid, Year Four as first filed |
|---|---|---|
| 2023-12-31 | $7.00K 10-K · filed 2025-04-15 | |
| 2023-09-30 | $7.00K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $7.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $7.00K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $7.00K 10-K · filed 2024-03-27 | |
| 2020-03-31 | $2.00 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $2.00 10-Q · filed 2020-05-11 | $2.00K 10-K · filed 2020-03-09 |
| 2019-09-30 | $19.00K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $19.00 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $18.90K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |